入选标准

主要入选标准为起病48h内入院的急性脑梗死／TIA病人。

Main inclusion criteria : acute cerebral infarction or TIA within 48h .

入选标准：正常组为经系统查体和冠状动脉CT检查排除冠心病的正常人；冠心病患者按照世界卫生组织WHO的冠心病的诊断标准进行分组。

Inclusion criteria : normal group cases were ruled out coronary heart disease by examination and coronary artery CT scan . We grouped CHD cases according to the diagnostic criteria of World Health Organization ( WHO ) . 2 .

病例入选标准：1.经CT扫描证实为自发颅内出血；

Admission rules : 1 . spontaneity intracerebral hemorrhage confirmed by CT scan .

对符合入选标准的325例急性脑梗死患者，应用西部失语成套测验进行失语症的分类，应用波士顿诊断性失语严重程度分级标准进行失语症严重程度分级，并进行CT、MRI检查。

Then the 325 inpatients were selected to carry out the western aphasia battery , grade criterion of the boston diagnostic aphasia and CT , MRI imaging .

方法共检索出符合入选标准的6个随机对照临床试验，采用固定效应模型和随机效应模型对826例患者的肿瘤反应率和毒性资料进行Meta分析。

Methods Data of 826 patients in 6 randomized trials were meta analyzed with fixed effect model or random effect model .

方法符合入选标准的患者随机分为两组：溶栓组（54例）先予UK150万U静脉滴注，随后给予常规药物治疗。

Methods Patients consistent with the inclusive criterion were randomized into two groups . The thrombolytic group ( 57 cases ) received UK 1.5 MU and routine medicine .

临床资料1090例ICU患者，研究对象的入选标准是严重创伤、休克、感染、外科急腹症、化学和物理因素损伤等所致脓毒症。

Methods : 1090 patients , who suffered from sepsis caused by trauma , shock and infection , were enrolled in this study .

以NIH-CDC阴性为入选标准的34例临床移植中，接受Flow-CDC阴性供肾的受者33例，术后仅1例+5d出现急性排斥经冲击治疗后逆转，Scr平均恢复时间为+6d；

In 33 recipients who received NIH-CDC and Flow-CDC both negative transplantation , 1 suffered from acute rejection .

入选标准为患者持续性胸痛并经心电图、心肌坏死标记物检查诊断为NSTEMI。

The inclusion criteria was patients with persistent chest pain and confirmed NSTEMI diagnosed by the ECG and the myocardial necrosis markers .

方法符合入选标准的96例颅内动脉狭窄患者根据其经济承受能力及自愿原则，分为支架成形术（SAA）组30例和内科药物治疗组66例。

Methods According to economic status and voluntary principle , 96 patient who met selection criterion were divided into SAA group including 33 patients and medication group including 66 patients .

方法对60名（男34名，女26名）符合入选标准的3~5岁健康小儿所排新鲜粪便进行直接称重、测量长度，并按Bristol标准分型。

Met - ( hods ) The fresh stools of 60 normal children ( male 34 , female 26 ) were measured , classify the stools according to Bristol ′ s scale .

迟发性帕金森病（late-onset，LOP）组：入选标准为患者起病年龄>40岁，共27例（男18例，女9例），起病年龄41～72岁，平均52.5±9.2岁。

LOP ( late-onset Parkinson disease ) group with onset age > 40 , 27 cases , 18 males , 9 females , with onset age between 41-72 , mean 52.5 + 9.2 years .

ICCA的入选标准为：3～20个月出现良性婴儿惊厥（BFIC）和在儿童后期或青春期出现发作性运动源性运动障碍（PKC）。

ICCA was defined as consisting of benign familial infantile convulsion ( BFIC ) in 3 ~ 20 months after birth and PKC occurring in later childhood or adolescence .

研究对象入选标准：1MR伴以下条件2项或以上：头面部异常特征，手足、生殖器或内脏器官先天异常发现，宫内生长发育迟缓史，生后异常生长发育，阳性家族史；

The patients were selected based on the following criteria : ① MR with two or more of the following conditions : dysmorphic features , prenatal growth retardation , postnatal growth abnormalities , a suggestive family history ;

两个组在入选标准上是相同的。

The2 groups were similar in terms of matched criteria .

请提供本品具体的入选标准。

Please provide the specific inclusion criteria for this product .

九项研究满足入选标准（参与者n=4522）。

Nine studies met the inclusion criteria ( n = 4522 participants ) .

有五项来自南亚的试验符合入选标准。

Five trials , all from south Asia , satisfied the inclusion criteria .

他们确定了研究入选标准。

They identified studies that met the inclusion criteria .

结果：按照入选标准最终有11项随机对照临床试验纳入本研究。

Result : According to included criteria , 11 studies were chosen at last .

方法24例符合入选标准的大手术患者，随机分为对照组与谷氨酰胺干预组，每组12例。

Methods 24 patients undergoing elective major surgery were randomly allocated to two groups .

入选标准包括原始研究、对同行的影响以及良好判断。

The criteria for inclusion was original research , influence on peers and sound judgment .

病例组和对照组的选择严格按照入选标准进行。

The case group and the control groups were strictly selected according to the diagnoses standards .

有3家不符合中心入选标准被除外，最后19家医院的资料被采用，总计有2283例卒中患者的数据纳入分析中。

A total of 2283 IS or TIA patients from 19 hospitals were included in the survey .

结果：共有372位接受抗肿瘤坏死因子治疗的患者满足入选标准。

RESULTS : A total of372 patients treated with anti-tumor necrosis factor therapies met the inclusion criteria .

新奇观的唯一入选标准是在公元2000年以前建造或者发现的。

The only criteria for the new list is that the landmarks were built or discovered before 2000 .

方法：本研究从临床选取符合入选标准的患者60例，随机分为两组，治疗组30例，对照组30例。

Methods : In clinic , 60 cases who fulfilled inclusion criteria were randomly classified into two groups .

最主要的入选标准是以缺血性卒中为基本诊断而收治者。

The major inclusion criterion was admission to an acute carefacility with a principal diagnosis of ischemic stroke .

24项研究符合入选标准：13项来自同行评议的文献，另外11项公布在网上。

Twenty-four studies met the inclusion criteria : 13 were from the peer-reviewed literature and11 were published on line .

研究对象的入选标准：注册护士；工作年限≥1年；知情并同意参与本研究。

The inclusion criteria : registered nurse ; work experience ≥ 1year ; informed consent to participate in this study .